Clinical practice guidelines for the care and treatment of breast cancer: The management of ductal carcinoma in situ (summary of the 2001 update)

CMAJ. Canadian Medical Association Journal

Volumn 165, Issue 7, 2001, Pages 912-913

  Olivotto, I ^a   Levine, M ^a  

^a MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BASEMENT MEMBRANE; BREAST CARCINOMA; BREAST DUCT; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CARCINOMA IN SITU; CELL PROLIFERATION; CLINICAL PRACTICE; CLINICAL TRIAL; HUMAN; MAMMOGRAPHY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; NOTE; PRACTICE GUIDELINE; SIDE EFFECT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035667297     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (8)

1. Clinical practice guidelines for the care and treatment of breast cancer: 5. The management of ductal carcinoma in situ (DCIS)
2. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces
3. Consensus conference on the classification of ductal carcinoma in situ
4. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17
5. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853
6. The influence of margin width on local control of ductal carcinoma in situ of the breast
7. Tamoxifen in the treatment of intraductal breast cancer: NSABP protocol B-24 randomized control trial
8. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer